BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• BioCapital

  J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology

  December 8, 2008

   · 

  6 min read
• Drug Development

  Sunesis Pharmaceuticals, Inc. Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology

  December 8, 2008

   · 

  8 min read
• Drug Development

  Presentation on Cytopia Limited’s JAK2 Inhibitor Program in Myeloproliferative Disorders

  December 8, 2008

   · 

  1 min read
• Drug Development

  Halozyme Therapeutics, Inc. Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

  December 8, 2008

   · 

  4 min read
• Deals

  bioMerieux, Inc. Acquires Culture Media Specialist PML Microbiologicals, Inc. Reinforcing Position in the North American Microbiology Market

  December 8, 2008

   · 

  2 min read
• Cardinal Health, Inc. Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data

  December 8, 2008

   · 

  4 min read
• Deals

  Affymetrix (Santa Clara, California) Completes Acquisition of Panomics, Inc.

  December 8, 2008

   · 

  4 min read
• Drug Development

  Ortho-McNeil Neurologics, Inc. Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures

  December 8, 2008

   · 

  6 min read
• Drug Development

  Genentech, Inc. (JOBS) Says Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer

  December 8, 2008

   · 

  9 min read
• Drug Development

  GlaxoSmithKline, Valeant Pharmaceuticals International Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy

  December 8, 2008

   · 

  6 min read